Month: July 2024

Skyhawk Therapeutics Announces Positive Topline Results from Parts A and B of its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease, Reaching 72% Huntingtin mRNA Reduction

Skyhawk’s SKY-0515 demonstrated dose-dependent huntingtin (HTT) mRNA reduction in healthy volunteers, with 72% reduction at the highest dose tested in...

Scanning Electrochemical Microscopy (SECM) Market size is set to grow by USD 55.8 million from 2024-2028, Miniaturization of electronic devices boost the market, Technavio

NEW YORK, July 9, 2024 /PRNewswire/ -- Scanning electrochemical microscopy (SECM) is used for imaging and analyzing chemical processes at...

error: Content is protected !!